期刊文献+

Gd-DTPA和BaSO_4在改善磁共振胰胆管成像质量中的应用 被引量:3

Gastrointestinal contrast agents for improving imaging quality of MRCP:comparison between Gd-DTPA and BaSO_4 suspension
暂未订购
导出
摘要 目的研究钆喷酸葡胺(Gd-DTPA)注射液和硫酸钡(BaSO4)混悬液在改善磁共振胰胆管成像(MRCP)质量方面的应用价值。方法体外实验中,研究MR信号强度与两种对比剂不同浓度之间的关系,拟定出最佳的浓度配比。临床研究中,将受检者随机分组,行口服对比剂前后MRCP检查,并配合MR增强扫描,对照研究不同浓度的Gd-DTPA和BaSO4对MRCP图像中胃肠道液体信号的影响。结果体外实验表明,浓度稀释10倍的Gd-DTPA和浓度为100%(W/V)的BaSO4抑制液体信号的效果理想;临床研究表明,所有病例口服Gd-DTPA稀释液后胃肠道内液体高信号均有明显下降(P<0.05),而BaSO4混悬液抑制效果欠佳。结论口服稀释Gd-DTPA注射液对胃肠道液体信号的抑制效果较好。口服稀释100倍的Gd-DTPA注射液并配合MR增强扫描,MRCP成像效果最佳。 Objective To assess and compare the effectiveness of gadolinium diethylenetriamine pentacetic acid (Gd-DTPA) solution and barium sulfate (BaSO4) suspension with different concentrations in improving the imaging quality of magnetic resonance eholangiopancreatography(MRCP). Methods The phantom study was carried out to determine the optimal concentration of Gd-DTPA and BaSO4 suspension used as an oral negative contrast agent in MRCP. The patients were grouped randomly and performed MRCP before and after using oral contrast agents in combination with intravenous injection of contrast agents. A comparison of the influence of BaSO4 suspension and Gd-DTPA with different concentrations on the signal intensity of the fluid in gastrointestinal tract on MRCP images was made. Results The phantom study showed that the dilution ratio 1:10 of Gd-DTPA solution and 100% (W/V)BaSO4 suspension were the optimal concentrations in decreasing the signal intensity. In all patients the high signal intensity of the gastrointestinal fluid was completely suppressed after oral administration of Gd-DTPA diluted solution (P 〈 0.05). However, the suppression effect of BaSO4 suspension was not ideal. Conclusion Gd-DTPA diluted solution may decrease the signal intensity of gastrointestinal liquid effectively. Oral administration of 1:100 diluted ratio of Gd-DTPA solution combined with Gd-DTPA intravenous injection may improve the imaging quality of MRCP.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第1期103-107,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 磁共振胰胆管成像 钆喷酸葡胺 硫酸钡 口服 磁共振成像 MRCP Gd-DTPA BaSO, oral administration MRI
  • 相关文献

参考文献9

  • 1Chan JH,Tsui EY,Yuen MK,et a1.Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP[J].Abdom Imaging,2000,25(4):405-408.
  • 2张照喜,陈建生,陈宪,徐宁,郑之青,蒋春林,刘玉林.口服静脉用钆喷酸葡胺稀释液改善MRCP质量的研究[J].临床放射学杂志,2004,23(9):777-780. 被引量:7
  • 3Maccioni F,Viscido A,Broglia L,et al.Evaluation of Crohn's disease activity with magnetic resonance imaging[J].Abdom Imaging,2000,25(3):219-228.
  • 4Maccioni F.Current status gastrointestinal MRI.Abdom Imaging,2002,27(2):358-360.
  • 5Chan JH,Tsui EY,Yuen MK,et al.Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP[J].Abdom Imaging,2000,25(4):405-408.
  • 6Papanikolaou N,Karantanas A,Maris T,et al.MR cholangiopancreatography before and after oral blueberry juice administration[J].J Comput Assist Tomogr,2000,24(2):229-234.
  • 7Giovagnoni A,Fabbri A,Maccioni F,et al.Oral contrast agents in MRI of the gastrointestinal tract[J].Abdom Imaging,2002,27(4):367-370.
  • 8Gourtsoyiannis N,Papanikolaou N,Grammatikakis J,et al.MR imaging of the small bowel with a true-FISP sequence after enteroclysis with water solution[J].Invest Radiol,2000,35(2):707-711.
  • 9杨忠,梁宗辉,冯晓源,李克.一种MRI口服胃肠道造影剂的实验研究[J].中国医学计算机成像杂志,2006,12(3):213-216. 被引量:1

二级参考文献22

  • 1戴平丰,刘继汉,余伟南.腹部磁共振成像应用口服造影剂枸橼酸铁铵的研究[J].中华放射学杂志,1994,28(6):407-411. 被引量:12
  • 2Takahashi S, Kim T, Murakami T,et al. Influence of paramagnetic contrast on single-shot MRCP image quality. Abdom Imaging, 2000, 25:511
  • 3Chan JH, Tsui EY, Yuen MK,et al.Gadopentetate dimeglumine as an oral negative gastrointestinal contrast agent for MRCP. Abdom Imaging, 2000, 25:405
  • 4刘定西,于群,主编.MR成像分册.武汉:湖北科学技术出版社,1999,121
  • 5卢延,张雪哲,主编.磁共振水成像.北京:科学出版社,2000.1
  • 6Brown JJ, Duncan JR, Heiken JP,et al. Perfluorodtybromide as a gastrointestinal contrast agent for MR imaging:use with and without glucagons.Radiology, 1991, 181:455
  • 7Hahn PF, Stark DD, Lewis JM,et al. First clinical trial of a new superparamagnetic irom oxide for use as an oral gastrointestinal contrast agent for MR imaging. Radiology, 1990, 175:695
  • 8Hirohashi S, Hirohashi R, Uchida H,et al. MR cholangiopancreatography and MR urography: improved enhancement with a negative oral contrast agent. Radiology, 1997, 203:281
  • 9Petersein J, Reisinger W, Mutze S,et al. Value of negative oral contrast media in MR cholangiopancreatography (MRCP). Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, 2000, 172:55
  • 10Malcolm PN, Brown JJ, Hahn PF, et al. The clinical value of ferric ammonium citrate: a positive oral contrast agent for T1 - weighted MR imaging of the upper abdomen. J Magn Reson Imaging, 2000,12:702 - 707

共引文献6

同被引文献25

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部